Literature DB >> 19565854

[Meta-analysis on the relationship between colorectal cancer and Helicobacter pylori infection].

Yan Zhang1, Chang Gao, Jing-Hua Zhai.   

Abstract

OBJECTIVE: Analyzing all the related studies that have been published in the world to evaluate the relationship between colorectal cancer (including colorectal adenomas) and Helicobacter pylori infection by means of Meta-analysis.
METHODS: To analyze the 14 references consistent with inclusion criteria by reviewing manager 4.2, calculating the odds ratio and 95% confidence interval, then drawing funnel plot. Results The total sample size is 3165, cases and controls are 1330 and 1835, respectively. The pooled OR is 1.36, and 95% confidence interval 1.01, 1.82. The graphical funnel plot appearing asymmetrical, but analyzing by sensitivity analysis and fail-safe number calculation. The results are affected by publication bias.
CONCLUSION: The results of our Meta-analysis show that Helicobacter pylori infection is a possible risk of colorectal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19565854

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Helicobacter pylori infection coexisting with intestinal metaplasia is not associated with colorectal neoplasms.

Authors:  Banu Boyuk; Arif Ozgur; Hande Atalay; Aslan Celebi; Ismail Ekizoglu; Engin Aykurt
Journal:  Prz Gastroenterol       Date:  2019-07-05

2.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

3.  Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans.

Authors:  Hassan Brim; Marwah Zahaf; Adeyinka O Laiyemo; Mehdi Nouraie; Guillermo I Pérez-Pérez; Duane T Smoot; Edward Lee; Hadie Razjouyan; Hassan Ashktorab
Journal:  BMC Cancer       Date:  2014-04-28       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.